alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 12,851–12,875 of 27,380 studies, newest first · page 515 of 1096.

May 2019 25

  1. 2019-05-10

    Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?

    ✓ Peer-reviewed Brain scans and imaging Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: We found no disease effects on retinal vascular measures (all β's < |0.15|, all P > .2), adjusted for confounders. +2 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2019-05-10

    Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy

    Key finding: We found brain volume reduction in the bilateral temporal, amygdala, parahippocampal and lower parietal lobe and left cingulate and precuneus regions (family-wise error, p < 0.05). +3 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2019-05-10

    Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5×FAD mouse model of Alzheimer's disease

    ✓ Peer-reviewed Drug development Behavioural brain research

    Key finding: Spatial memory test showed that exenatide administration (100 μg/kg twice per day) prevented cognitive decline after 16 weeks of treatment. +1 more finding

    Full summary, score breakdown and related studies → Original source

  4. 2019-05-09

    Association between Statin Use and Sepsis Risk in Patients with Dementia: A Retrospective Cohort Study

    ✓ Peer-reviewed Treatments International journal of environmental research and public health

    Key finding: In conclusion, our analysis showed no positive association of sepsis with statin use in patients with dementia.

    Full summary, score breakdown and related studies → Original source

  5. 2019-05-09

    Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers

    ✓ Peer-reviewed Brain scans and imaging Experimental & molecular medicine

    Key finding: However, research attempting to establish the reliability of Aβ and tau as biomarkers has culminated in an amalgamation of contradictory results and theories regarding the biomarker concentrations necessary for an accurate diagnosis.

    Full summary, score breakdown and related studies → Original source

  6. 2019-05-09

    Your Robot Therapist Will See You Now: Ethical Implications of Embodied Artificial Intelligence in Psychiatry, Psychology, and Psychotherapy

    ✓ Peer-reviewed Prevention and risk Journal of medical Internet research

    Key finding: From an ethical perspective, important benefits of embodied AI applications in mental health include new modes of treatment, opportunities to engage hard-to-reach populations, better patient response, and freeing up time for physicians. +1 more finding

    Full summary, score breakdown and related studies → Original source

  7. 2019-05-09

    Alzheimer's disease: risk factors and potentially protective measures

    ✓ Peer-reviewed Prevention and risk Journal of biomedical science

    Key finding: As a complement, some protective factors associated with a lower risk of disease incidence, such as cognitive reserve, physical activity and diet will also be addressed.

    Full summary, score breakdown and related studies → Original source

  8. 2019-05-08

    Determinants of self- and carer-rated quality of life and caregiver burden in Alzheimer disease

    ✓ Peer-reviewed Caregiving International journal of geriatric psychiatry

    Key finding: There was a strong correlation between carer- and self-rated QoL, with patients consistently rating their QoL higher than caregivers. +4 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2019-05-08

    Elevated cerebrospinal fluid total tau in former professional athletes with multiple concussions

    ✓ Peer-reviewed Tau biomarkers Neurology

    Key finding: Concentrations of phosphorylated tau181, total tau (t-tau), and β-amyloid in the CSF were measured in 3 groups: 22 former professional athletes with multiple concussions (mean ± SD age 55.9 ± 12.2 years), 5 healthy controls (age 57.4 ± 5.2 years), and 12 participants (age 60.0 ± 6.6 years) diagnosed with Alzheimer disease (AD). +3 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2019-05-08

    TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers

    ✓ Peer-reviewed Risk genes beyond APOE Molecular neurodegeneration

    Key finding: Low frequency coding variants in TREM2 are associated with Alzheimer disease (AD) risk and cerebrospinal fluid (CSF) TREM2 protein levels are different between AD cases and controls. +3 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2019-05-08

    Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: In MCI reverters, abnormal biomarkers for AD pathology are associated with subsequent decline. +1 more finding

    Full summary, score breakdown and related studies → Original source

  12. 2019-05-07

    Blindness and Visual Impairment in the Medicare Population: Disparities and Association with Hip Fracture and Neuropsychiatric Outcomes

    ✓ Peer-reviewed Digital health tools Ophthalmic epidemiology

    Key finding: The prevalence of low vision in the Medicare population was 994/100,000 and increased significantly with age, Black (1,854/100,000) or Hispanic (2,862/100,000) race/ethnicity, female gender (1,181/100,000), and Medicaid eligibility (2,975/100,000). +3 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2019-05-07

    Gamma Entrainment Binds Higher-Order Brain Regions and Offers Neuroprotection

    ✓ Peer-reviewed Lewy body dementia Neuron

    Key finding: Recently, we showed that inducing gamma oscillations with visual stimulation (gamma entrainment using sensory stimuli, or GENUS) reduced amyloid plaques and phosphorylated tau in multiple mouse models. +1 more finding

    Full summary, score breakdown and related studies → Original source

  14. 2019-05-07

    Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses

    ✓ Peer-reviewed Down syndrome and Alzheimer's Frontiers in neuroscience

    Key finding: We place these findings in the context of the selective, but by no means unique, involvement of BFCNs and their trophic dependence on NGF signaling and speculate as to how pathogenesis in these neurons is initiated, amplified and ultimately results in their dysfunction and death. +1 more finding

    Full summary, score breakdown and related studies → Original source

  15. 2019-05-07

    A longitudinal study of speech production in primary progressive aphasia and behavioral variant frontotemporal dementia

    ✓ Peer-reviewed Digital health tools Brain and language

    Key finding: All patient groups declined significantly on measures of both speech fluency and grammar, although patients with nonfluent/agrammatic PPA (naPPA) declined to a greater extent than patients with the semantic variant, the logopenic variant, and bvFTD. +1 more finding

    Full summary, score breakdown and related studies → Original source

  16. 2019-05-07

    Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway

    ✓ Peer-reviewed How common it is mBio

    Key finding: Alzheimer's disease (AD), the most common cause of dementia, has long been associated with bacterial infections and inflammation-causing immunosenescence. +4 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2019-05-06

    Palliative care for people with dementia living at home: A systematic review of interventions

    ✓ Peer-reviewed End-of-life care Palliative medicine

    Key finding: The review highlights the paucity of high-quality dementia-specific research in this area and recommends key areas for future work, for example, the need for process evaluation to identify facilitators and barriers to implementing interventions.

    Full summary, score breakdown and related studies → Original source

  18. 2019-05-04

    Transcriptomic analysis of probable asymptomatic and symptomatic alzheimer brains

    ✓ Peer-reviewed Brain scans and imaging Brain, behavior, and immunity

    Key finding: Differential expression analysis identified a significant increase of transcriptomic activity in the frontal cortex of AsymAD subjects, suggesting fundamental changes in AD may initially begin within the frontal cortex region prior to AD diagnosis.

    Full summary, score breakdown and related studies → Original source

  19. 2019-05-04

    Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort

    ✓ Peer-reviewed Getting a diagnosis Brain, behavior, and immunity

    Key finding: Recently, several animal studies indicated that the 'gut-brain' axis might contribute to the amyloid deposition of AD. +4 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2019-05-03

    Advances in cerebral amyloid angiopathy imaging

    ✓ Peer-reviewed Vascular contributions Therapeutic advances in neurological disorders

    Key finding: The vascular injuries of CAA result in both hemorrhagic and ischemic manifestations and related structural changes on MRI, including cerebral microbleeds, cortical superficial siderosis, white matter hyperintensity, MRI-visible perivascular spaces, and cortical microinfarcts.

    Full summary, score breakdown and related studies → Original source

  21. 2019-05-03

    Comparative Effectiveness of Behavioral Interventions on Quality of Life for Older Adults With Mild Cognitive Impairment: A Randomized Clinical Trial

    ✓ Peer-reviewed Cognitive tests and assessment JAMA network open

    Key finding: These results provide further support for behavioral interventions for persons with MCI. +3 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2019-05-03

    Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment

    ✓ Peer-reviewed Brain scans and imaging JAMA network open

    Key finding: In this study, lower AD signature region volumes, brain microhemorrhages, higher WMH volumes, and infarcts were risk factors associated with dementia in older community-based residents. +3 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2019-05-02

    Galantamine plasma concentration and cognitive response in Alzheimer's disease

    ✓ Peer-reviewed Treatments PeerJ

    Key finding: The total sample consisted of 33 clinically diagnosed AD patients taking galantamine 8 mg/d for 6 months. +4 more findings

    Full summary, score breakdown and related studies → Original source

  24. 2019-05-01

    Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective

    ✓ Peer-reviewed Genetics International journal of molecular sciences

    Key finding: Carriers of an ε4 allele have an increased risk of developing AD, while those with an ε2 allele are protected. +1 more finding

    Full summary, score breakdown and related studies → Original source

  25. 2019-05-01

    Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99)

    ✓ Peer-reviewed Down syndrome and Alzheimer's The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: Direct measurements of lysosomal pH uncovered a significant elevation (0.6 units) as a basis for slowed LC3 turnover and the inactivation of cathepsin D and other lysosomal hydrolases known to be unstable or less active when lysosomal pH is persistently elevated. +1 more finding

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →